Latest filing published 02 Apr 2026 for 서린바이오.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Since each purchase
- -29.0%Entry ₩6,100 · Close at T+90 ₩4,330
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
강미옥: trading record in brief
강미옥 is a declared insider of 서린바이오 (chief executive), with filings sourced from DART (FSS). We count 3 filings; the first trade dates from 18 March 2022 and the latest from 26 March 2026.
No open-market sale appears; the market trades are 3 purchases. The amount is not disclosed for 3 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 2 purchases and no sales on the market.
On 2 April 2026 came the latest disclosure, an open-market purchase in 서린바이오. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 강미옥
Open company profiles for insider transactions, fundamentals and analyst consensus when available.